News-Medical.Net on MSN
Aptamer Group and Alphazyme execute licensing agreement for synthetic aptamer-based enzyme modulation in hot-start PCR
Aptamer Group plc, a developer of synthetic oligonucleotide-based binding reagents for life sciences applications, and ...
The York-based Aptamer Group says it ends 2025 with strong momentum as global pharma partnerships drive confidence for 2026.
In a breakthrough that defies nature, Northwestern University and Stanford University synthetic biologists have created a new ...
Interesting Engineering on MSN
Synthetic metabolism offers new way to convert CO2 into usable industrial materials
Scientists build a synthetic metabolism that converts CO2-derived formate into valuable chemicals outside living cells.
Natural biological systems cannot efficiently convert waste CO₂ or its derivatives into useful building-block chemicals at a scale that can keep pace with rising atmospheric carbon. Engineer a fully ...
Although it also performs some functions in men, estrogen, the main female sex hormone, is involved in a myriad of processes, ...
News-Medical.Net on MSN
New insights into how a molecular gatekeeper controls early protein modification
For years, ETH researchers have been investigating a molecular complex that plays a key role in protein synthesis. They have ...
Gilead Sciences, Inc. (Nasdaq: GILD) and Assembly Biosciences, Inc. (Nasdaq: ASMB), today announced Gilead has exercised its combined option to exclusively license Assembly Bio’s herpes simplex virus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback